cas 1672663-10-3|| where to buy 4-Fluoro-7-(methylthio)-2,3-dihydro-1H-inden-1-one

Nombre del producto:4-Fluoro-7-(methylthio)-2,3-dihydro-1H-inden-1-one

IUPAC Name:4-fluoro-7-(methylsulfanyl)-2,3-dihydro-1H-inden-1-one

Unidad de embalaje	Stock disponible	Precio($)	Cantidad
CM290140-1g	in stock	ŭşƻƩ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1672663-10-3 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :1672663-10-3; Fórmula molecular:C10H9FOS; Punto de fusión:-; Código de sonrisas:O=C1CCC2=C1C(SC)=CC=C2F; Densidad:

: Número de catálogo:CM290140; Peso molecular:196.24; Punto de ebullición:; Nº Mdl:; Almacenamiento:

: Indenes; Indenes are useful building blocks found in a variety of biologically relevant products.

: Belzutifan; On September 19, MSD announced that the U.S. FDA has accepted and granted priority review for a supplemental new drug application (sNDA) seeking approval for Welireg (Belzutifan), Merck's oral hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor, for the treatment of adult patients with advanced renal cell carcinoma (RCC). Welireg was the first HIF-2α inhibitor therapy approved in the U.S. and is currently approved for the treatment of adult patients with von Hippel-Lindau (VHL) disease who require therapy for associated RCC, central nervous system hemangioblastomas, or pancreatic neuroendocrine tumors, not requiring immediate surgery.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.